KAZIA THERAPEUTICS LTD KZIA
- paxalisib — Glioblastoma Phase 2
- paxalisib — Triple-Negative Breast Cancer Phase 1
- paxalisib — Diffuse Intrinsic Pontine Glioma
- paxalisib — Atypical Rhabdoid/Teratoid Tumors Phase 2
mTOR (2 companies · 5 programs)
Companies with an active program directed at mTOR.
Quoin Pharmaceuticals, Ltd. QNRX
- rapamycin Preclinical